Search

The article focuses on a study which tries to identify the risk factors associated with the infection of multiple antibiotic-resistant Pseudomonas aeruginosa (MARPA) in patients with cystic fibrosis (CF). The fiver-year study revealed that risk factors for MARPA include diabetes, long-term inhaled tobramycin usage, and frequent acute pulmonary exacerbations requiring hospitalization or IV antibiotics.

The article presents a study which aims to examine the effectiveness of Levofloxacin in treating cystic fibrosis (CF) patients. Numerous data revealed that CF levofloxacin pharmacokinetics corrected for body weight are similar to non-CF but the standard levofloxacin dosing is unlikely to produce maximum therapeutic effectiveness. Thus, further levofloxacin CF studies are essential to assess its phlegm concentrations for coping Pseudomonas Aeruginosa pulmonary infections.

The article reports on the connection between lung function, depression, and health-related quality of life (HRQoL) among adults with cystic fibrosis (CF). It is posed that more than 40 percent of people born with CF now reached adulthood. In this study, the Beck Depression Inventory and the Cystic Fibrosis Questionnaire were employed to assess depressive symptoms and the HRQoL of 76 adults who were taken as subjects of the research.

The article discusses a study which examined the appropriate goal level for 25-hydroxyvitamin D in cystic fibrosis (CF). The study involved 216 patients with CF who were treated with vitamin D2. It was discovered that inadequate serum 25OHD levels are common in adults with CF and are associated with elevated parathyroid hormone (PTH) levels.